Patent details
301039
Product Name:
Fostamatinib of een farmaceutisch aanvaardbaar zout van fostamatinib, of een hydraat, solvaat of N-oxide van fostamatinib of het farmaceutisch aanvaardbare zout van fostamatinib, in het bijzonder dinatriumfostamatinib eventueel in de vorm van een hydraat
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
301039
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1856135
Status:
SPC in force
Application number:
301039
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)
Marketing Authorization
Marketing Authorization Number:
EU/1/19/1405
Marketing Authorization Type:
EEA
Marketing Authorization Date:
13/01/2020
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
28/04/2020
First Marketing Authorization date:
13/01/2020
Grant date:
12/05/2020
Activation date:
19/01/2026
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
29/04/2020
SPC/SPC Extension Expiration Date:
18/01/2031
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
28/04/2020
Name:
Rigel Pharmaceuticals, Inc.
Address:
1180 Veterans Blvd., 94080, South San Francisco, California, United States of America (US)
Agent
Name:
ir. F.A. Geurts c.s.
From:
28/04/2020
Address:
Octrooibureau Vriesendorp & Gaade B.V.
Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
SPC
Journal edition number:
03/26
Publication date:
21/01/2026
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
2
Bulletin Heading:
SPC
Journal edition number:
20/20
Publication date:
13/05/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
Bulletin Heading:
SPC
Journal edition number:
18/20
Publication date:
29/04/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Annual Fee
Annual Fee(s) Due Date:
31/01/2027
Annual Fee Number:
22
Annual Fee Amount:
1800 Euro
Last Annual Payment Date:
29/12/2025
Last Annual Fee Paid Number:
21
Last Annual Fee Paid Amount:
1600 Euro
Payer:
Computer Packages Inc. (CPI)
Filing date
Document type
Document Description
Number of pages
File Type
12/05/2020
Front Page
Front Page
1
PDF
/2/2/0/6/4/0800546022/docs/301039_0_i2frontpage20200512121345896.pdf
12/05/2020
Certificate
Certificate
1
PDF
/2/2/0/6/4/0800546022/docs/301039_6_spcmedcertificate20200512121546047.pdf
12/05/2020
Outgoing Correspondence
Decision grant
2
PDF
/2/2/0/6/4/0800546022/docs/301039_9_343700l504a.pdf
29/04/2020
Outgoing Correspondence
Confirmation receipt request
1
PDF
/2/2/0/6/4/0800546022/docs/301039_2_341555l174.pdf
29/04/2020
Front Page
Front Page
1
PDF
/2/2/0/6/4/0800546022/docs/301039_4_i1frontpage20200429111723254.pdf
28/04/2020
SPC Documents
Annex SPC
1
PDF
/2/2/0/6/4/0800546022/docs/301039_1_supplprotectioncertificate20200428043524993.pdf
28/04/2020
SPC Documents
Marketing Authorization SPC
3
PDF
/2/2/0/6/4/0800546022/docs/301039_3_supplprotectioncertificate20200428043525053.pdf
28/04/2020
SPC Documents
Summary of the characteristics of the product
20
PDF
/2/2/0/6/4/0800546022/docs/301039_5_supplprotectioncertificate20200428043525115.pdf
28/04/2020
Application Form
First filed application form
4
PDF
/2/2/0/6/4/0800546022/docs/301039_7_applicationform20200428043524875.pdf
28/04/2020
SPC Documents
Annex SPC
3
PDF
/2/2/0/6/4/0800546022/docs/301039_8_supplprotectioncertificate20200428043525175.pdf